FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2000911773> ?p ?o ?g. }

• W2000911773 endingPage "1588" @default.
• W2000911773 startingPage "1582" @default.
• W2000911773 abstract "Monotherapy has been proven insufficient in achieving sustained control of chronic hepatitis B. We aimed to assess the efficacy of combined sequential administration of lamivudine and pegylated interferon alfa-2b in patients with hepatitis Be antigen (HBeAg)-negative chronic hepatitis B.Eighteen patients were given sequential combination treatment starting with 3 months of lamivudine monotherapy followed by 9 months of pegylated interferon alfa-2b (after a 3-month period of concomitant administration of the two drugs) and 24 patients received lamivudine monotherapy.At the end of treatment, 88.9% of the patients who received sequential combination treatment and 70.8% of those who received lamivudine monotherapy had hepatitis B virus (HBV) DNA levels below 400 copies/mL (P = not significant). At the end of treatment, 72.2% of the patients who received sequential combination treatment and 70.8% of those who received lamivudine monotherapy achieved alanine aminotransferase normalization (P = not significant). After 12 months of follow up, 33.3% of the patients who received sequential combination treatment and 16.7% of those who received lamivudine monotherapy had HBV-DNA levels below 400 copies/mL (P = 0.4). After 12 months of follow up, 72.2% of the patients who received sequential combination treatment and 25.0% of those who received lamivudine monotherapy had normal alanine aminotransferase levels (P < 0.01). Twenty-five percent of the patients in the lamivudine monotherapy group had virological breakthrough compared to none in the sequential combination treatment group (P = 0.06).Sequential combination treatment is able to improve sustained biochemical response rates and prevent the emergence of lamivudine-resistant mutants in patients with HBeAg-negative chronic hepatitis B." @default.
• W2000911773 created "2016-06-24" @default.
• W2000911773 creator A5009252252 @default.
• W2000911773 creator A5011620102 @default.
• W2000911773 creator A5019121947 @default.
• W2000911773 creator A5021164432 @default.
• W2000911773 creator A5022719786 @default.
• W2000911773 creator A5023595958 @default.
• W2000911773 creator A5024706891 @default.
• W2000911773 creator A5029841270 @default.
• W2000911773 creator A5038132726 @default.
• W2000911773 creator A5042677752 @default.
• W2000911773 creator A5052241991 @default.
• W2000911773 creator A5068300013 @default.
• W2000911773 creator A5070469560 @default.
• W2000911773 creator A5076157401 @default.
• W2000911773 creator A5087258011 @default.
• W2000911773 date "2007-08-07" @default.
• W2000911773 modified "2023-10-10" @default.
• W2000911773 title "Lamivudine/pegylated interferon alfa-2b sequential combination therapy compared with lamivudine monotherapy in HBeAg-negative chronic hepatitis B" @default.
• W2000911773 cites W1965747579 @default.
• W2000911773 cites W1972774048 @default.
• W2000911773 cites W1972979898 @default.
• W2000911773 cites W1978724373 @default.
• W2000911773 cites W1983757435 @default.
• W2000911773 cites W1992194872 @default.
• W2000911773 cites W2003797046 @default.
• W2000911773 cites W2012090731 @default.
• W2000911773 cites W2032153894 @default.
• W2000911773 cites W2040740844 @default.
• W2000911773 cites W2045811845 @default.
• W2000911773 cites W2049234248 @default.
• W2000911773 cites W2051060482 @default.
• W2000911773 cites W2051277974 @default.
• W2000911773 cites W2052968140 @default.
• W2000911773 cites W2055480646 @default.
• W2000911773 cites W2056089018 @default.
• W2000911773 cites W2063846412 @default.
• W2000911773 cites W2069030584 @default.
• W2000911773 cites W2074909664 @default.
• W2000911773 cites W2077300867 @default.
• W2000911773 cites W2084720260 @default.
• W2000911773 cites W2086962806 @default.
• W2000911773 cites W2094608386 @default.
• W2000911773 cites W2097754581 @default.
• W2000911773 cites W2111278668 @default.
• W2000911773 cites W2119612879 @default.
• W2000911773 cites W2120128540 @default.
• W2000911773 cites W2132254613 @default.
• W2000911773 cites W2133291642 @default.
• W2000911773 cites W2136425954 @default.
• W2000911773 cites W2137001989 @default.
• W2000911773 cites W2141908550 @default.
• W2000911773 cites W2144297979 @default.
• W2000911773 cites W2149337924 @default.
• W2000911773 cites W2156766277 @default.
• W2000911773 cites W2169631718 @default.
• W2000911773 cites W2175117246 @default.
• W2000911773 cites W2293495463 @default.
• W2000911773 cites W2410416037 @default.
• W2000911773 cites W2531646094 @default.
• W2000911773 cites W4232116493 @default.
• W2000911773 cites W4235965176 @default.
• W2000911773 cites W4367435828 @default.
• W2000911773 doi "https://doi.org/10.1111/j.1440-1746.2007.05103.x" @default.
• W2000911773 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17683500" @default.
• W2000911773 hasPublicationYear "2007" @default.
• W2000911773 type Work @default.
• W2000911773 sameAs 2000911773 @default.
• W2000911773 citedByCount "15" @default.
• W2000911773 countsByYear W20009117732012 @default.
• W2000911773 countsByYear W20009117732013 @default.
• W2000911773 countsByYear W20009117732014 @default.
• W2000911773 countsByYear W20009117732015 @default.
• W2000911773 countsByYear W20009117732018 @default.
• W2000911773 countsByYear W20009117732019 @default.
• W2000911773 crossrefType "journal-article" @default.
• W2000911773 hasAuthorship W2000911773A5009252252 @default.
• W2000911773 hasAuthorship W2000911773A5011620102 @default.
• W2000911773 hasAuthorship W2000911773A5019121947 @default.
• W2000911773 hasAuthorship W2000911773A5021164432 @default.
• W2000911773 hasAuthorship W2000911773A5022719786 @default.
• W2000911773 hasAuthorship W2000911773A5023595958 @default.
• W2000911773 hasAuthorship W2000911773A5024706891 @default.
• W2000911773 hasAuthorship W2000911773A5029841270 @default.
• W2000911773 hasAuthorship W2000911773A5038132726 @default.
• W2000911773 hasAuthorship W2000911773A5042677752 @default.
• W2000911773 hasAuthorship W2000911773A5052241991 @default.
• W2000911773 hasAuthorship W2000911773A5068300013 @default.
• W2000911773 hasAuthorship W2000911773A5070469560 @default.
• W2000911773 hasAuthorship W2000911773A5076157401 @default.
• W2000911773 hasAuthorship W2000911773A5087258011 @default.
• W2000911773 hasConcept C126322002 @default.
• W2000911773 hasConcept C159047783 @default.
• W2000911773 hasConcept C2522874641 @default.
• W2000911773 hasConcept C2775940106 @default.
• W2000911773 hasConcept C2776178377 @default.
• W2000911773 hasConcept C2776461080 @default.

• next